Shenogen is focused on the discovery and development of first-in-class therapeutics for cancer treatment. After years of efforts, we have developed an impressive

Shenogen Pharma Group is a drug discovery and development company founded in 2006 based in Beijing, China that dedicated the development of first-in-class therapeutics for cancer treatment. We possess robust intellectual property rights around a novel membrane-bound estrogen receptor, ER-alpha 36, which is related to tumor metastasis...

About Us

Pipeline

product pipeline consisting of small molecule and antibody drugs. Our products are safe and efficient, specifically targeting a novel estrogen receptor ER-alpha 36...

    NEWS